Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080015
Status:
COMPLETED
Last Update Posted:
2020-04-29
First Post:
2004-03-19
Brief Title:
Diflomotecan BN80915 Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer SCLC
Sponsor:
Ipsen
Organization:
Ipsen
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Small Cell Lung Cancer |
Keywords: